Skip to main content
NCBI home page
Quality in Health Care : QHC logoLink to Quality in Health Care : QHC
. 2001 Sep;10(Suppl 1):i61–i66. doi: 10.1136/qhc.0100061..

Preferences and understanding their effects on health*

K McPherson, A Britton
PMCID: PMC1765745  PMID: 11533441

Abstract

Preference for a particular intervention may, possibly via complicated pathways, itself confer an outcome advantage which will be subsumed in unblind randomised trials as part of the measured effectiveness of the intervention. Where more attractive interventions are compared with less attractive ones, any difference could therefore be a consequence of attractiveness and not its intrinsic worth. For health promotion interventions this is clearly important, but we cannot tell how important it is for therapeutic interventions without special studies to measure or refute such effects. These are difficult to do and are complex. Until the therapeutic effects of preference itself are more clearly understood, understanding the true therapeutic effects will be compromised, at least in principle.

Key Words: patient preference; randomised controlled trials; measurement

Full Text

The Full Text of this article is available as a PDF (138.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brewin C. R., Bradley C. Patient preferences and randomised clinical trials. BMJ. 1989 Jul 29;299(6694):313–315. doi: 10.1136/bmj.299.6694.313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cassileth B. R., Lusk E. J., Miller D. S., Brown L. L., Miller C. Psychosocial correlates of survival in advanced malignant disease? N Engl J Med. 1985 Jun 13;312(24):1551–1555. doi: 10.1056/NEJM198506133122406. [DOI] [PubMed] [Google Scholar]
  3. Chalmers I. What is the prior probability of a proposed new treatment being superior to established treatments? BMJ. 1997 Jan 4;314(7073):74–75. doi: 10.1136/bmj.314.7073.74a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Di Blasi Z., Harkness E., Ernst E., Georgiou A., Kleijnen J. Influence of context effects on health outcomes: a systematic review. Lancet. 2001 Mar 10;357(9258):757–762. doi: 10.1016/s0140-6736(00)04169-6. [DOI] [PubMed] [Google Scholar]
  5. Kleijnen J., de Craen A. J., van Everdingen J., Krol L. Placebo effect in double-blind clinical trials: a review of interactions with medications. Lancet. 1994 Nov 12;344(8933):1347–1349. doi: 10.1016/s0140-6736(94)90699-8. [DOI] [PubMed] [Google Scholar]
  6. Levy S. M., Herberman R. B., Lee J., Whiteside T., Beadle M., Heiden L., Simons A. Persistently low natural killer cell activity, age, and environmental stress as predictors of infectious morbidity. Nat Immun Cell Growth Regul. 1991;10(6):289–307. [PubMed] [Google Scholar]
  7. Lilford R. J., Jackson J. Equipoise and the ethics of randomization. J R Soc Med. 1995 Oct;88(10):552–559. [PMC free article] [PubMed] [Google Scholar]
  8. Macintyre I. M. Tribulations for clinical trials. BMJ. 1991 May 11;302(6785):1099–1100. doi: 10.1136/bmj.302.6785.1099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. McPherson K., Britton A. R., Wennberg J. E. Are randomized controlled trials controlled? Patient preferences and unblind trials. J R Soc Med. 1997 Dec;90(12):652–656. doi: 10.1177/014107689709001205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. McPherson K. Patients' preferences and randomised trials. Lancet. 1996 Apr 20;347(9008):1119–1119. [PubMed] [Google Scholar]
  11. McPherson K. The Cochrane Lecture. The best and the enemy of the good: randomised controlled trials, uncertainty, and assessing the role of patient choice in medical decision making. J Epidemiol Community Health. 1994 Feb;48(1):6–15. doi: 10.1136/jech.48.1.6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Moffett J. K., Torgerson D., Bell-Syer S., Jackson D., Llewlyn-Phillips H., Farrin A., Barber J. Randomised controlled trial of exercise for low back pain: clinical outcomes, costs, and preferences. BMJ. 1999 Jul 31;319(7205):279–283. doi: 10.1136/bmj.319.7205.279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Omenn G. S., Goodman G. E., Thornquist M. D., Balmes J., Cullen M. R., Glass A., Keogh J. P., Meyskens F. L., Valanis B., Williams J. H. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med. 1996 May 2;334(18):1150–1155. doi: 10.1056/NEJM199605023341802. [DOI] [PubMed] [Google Scholar]
  14. Phillips D. P., Ruth T. E., Wagner L. M. Psychology and survival. Lancet. 1993 Nov 6;342(8880):1142–1145. doi: 10.1016/0140-6736(93)92124-c. [DOI] [PubMed] [Google Scholar]
  15. Phillips D. P., Ruth T. E., Wagner L. M. Psychology and survival. Lancet. 1993 Nov 6;342(8880):1142–1145. doi: 10.1016/0140-6736(93)92124-c. [DOI] [PubMed] [Google Scholar]
  16. Redd W. H., Silberfarb P. M., Andersen B. L., Andrykowski M. A., Bovbjerg D. H., Burish T. G., Carpenter P. J., Cleeland C., Dolgin M., Levy S. M. Physiologic and psychobehavioral research in oncology. Cancer. 1991 Feb 1;67(3 Suppl):813–822. doi: 10.1002/1097-0142(19910201)67:3+<813::aid-cncr2820671411>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  17. Rücker G. A two-stage trial design for testing treatment, self-selection and treatment preference effects. Stat Med. 1989 Apr;8(4):477–485. doi: 10.1002/sim.4780080411. [DOI] [PubMed] [Google Scholar]
  18. Sackett D. L., Wennberg J. E. Choosing the best research design for each question. BMJ. 1997 Dec 20;315(7123):1636–1636. doi: 10.1136/bmj.315.7123.1636. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Silverman W. A., Altman D. G. Patients' preferences and randomised trials. Lancet. 1996 Jan 20;347(8995):171–174. doi: 10.1016/s0140-6736(96)90347-5. [DOI] [PubMed] [Google Scholar]
  20. Skovlund E. Should we tell trial patients that they might receive placebo? Lancet. 1991 Apr 27;337(8748):1041–1041. doi: 10.1016/0140-6736(91)92701-3. [DOI] [PubMed] [Google Scholar]
  21. Torgerson D. J., Klaber-Moffett J., Russell I. T. Patient preferences in randomised trials: threat or opportunity? J Health Serv Res Policy. 1996 Oct;1(4):194–197. doi: 10.1177/135581969600100403. [DOI] [PubMed] [Google Scholar]
  22. Ward E., King M., Lloyd M., Bower P., Sibbald B., Farrelly S., Gabbay M., Tarrier N., Addington-Hall J. Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy, and usual general practitioner care for patients with depression. I: clinical effectiveness. BMJ. 2000 Dec 2;321(7273):1383–1388. doi: 10.1136/bmj.321.7273.1383. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Quality in Health Care : QHC are provided here courtesy of BMJ Publishing Group

RESOURCES